TY - JOUR
T1 - TCGA divides gastric cancer into four molecular subtypes
T2 - Implications for individualized therapeutics
AU - Zhang, Wei
N1 - Publisher Copyright:
© 2014, Landes Bioscience. All rights reserved.
PY - 2014
Y1 - 2014
N2 - Gastric cancer is a leading cause of cancer deaths in the world. The treatment of gastric cancer is challenging because of its highly heterogeneous etiology and clinical characteristics. Recent genomic and molecular characterization of gastric cancer, especially the findings reported by the Cancer Genome Atlas (TCGA), have shed light on the heterogeneity and potential targeted therapeutics for four different subtypes of gastric cancer.
AB - Gastric cancer is a leading cause of cancer deaths in the world. The treatment of gastric cancer is challenging because of its highly heterogeneous etiology and clinical characteristics. Recent genomic and molecular characterization of gastric cancer, especially the findings reported by the Cancer Genome Atlas (TCGA), have shed light on the heterogeneity and potential targeted therapeutics for four different subtypes of gastric cancer.
UR - http://www.scopus.com/inward/record.url?scp=84907506211&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84907506211&partnerID=8YFLogxK
U2 - 10.5732/cjc.014.10117
DO - 10.5732/cjc.014.10117
M3 - Editorial
C2 - 25223913
AN - SCOPUS:84907506211
SN - 1000-467X
VL - 33
SP - 469
EP - 470
JO - Chinese Journal of Cancer
JF - Chinese Journal of Cancer
IS - 10
ER -